In Q1'26, Eli Lilly's (LLY) net income reached $7.40B USD, marking a significant increase from the previous quarter's $6.64B USD and representing the highest value in the observed period from Q2'23 to Q1'26. The net income trend shows substantial overall growth, with values rising from $1.76B USD in Q2'23 to $7.40B USD in Q1'26, despite a notable dip to a $57M USD loss in Q3'23; year-over-year growth has been predominantly positive, peaking at 1,790% in Q3'24 before stabilizing around 50-168% in recent quarters, indicating strong recovery and sustained profitability momentum in this bar and line chart visualization.